Angiotensin II increases norepinephrine turnover in the anteroventral third ventricle of spontaneously hypertensive rats

Hypertension

Volumn 28, Issue 2, 1996, Pages 224-227

  Tsukashima, Akira ^a   Tsuchihashi, Takuya ^a   Abe, Isao ^a   Nakamura, Kaoru ^b   Uchimura, Hideyuki ^b   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Hizen National Mental Hospital   (Japan)

Author keywords

angiotensin II; brain; hypertension, genetic; nervous system; norepinephrine; rats, inbred SHR

Indexed keywords

ANGIOTENSIN; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN THIRD VENTRICLE; HYPERTENSION; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0029761588     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.2.224     Document Type: Article

References (28)

1. Phillips MI, Kimura B. Brain angiotensin in the developing spontaneously hypertensive rat. J Hypertens. 1988;6:607-612.
2. Hoffman WE, Phillips MI, Schmid PG. Central angiotensin II-induced responses in spontaneously hypertensive rats. Am J Physiol. 1977;232:H426-H433.
3. Phillips MI, Mann JFE, Haebara H, Hoffman WE, Dietz R, Schelling P, Ganten D. Lowering of hypertension by central saralasin in the absence of plasma renin. Nature. 1977;270:445-447.
4. Sweet CS, Columbo JM, Gaul SC. Central antihypertensive effects of inhibitors of the renin-angiotensin system in rats. Am J Physiol. 1976;231:1794-1799.
5. Stamler JF, Brody MJ, Phillips MI. The central and peripheral effects of captopril (SQ 14225) on the arterial pressure of the spontaneously hypertensive rat. Brain Res. 1980;186:499-503.
6. Unger TH, Kaufmann-Buhler I, Schoelken B, Ganten D. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats. Eur J Pharmacol. 1981;70:173-177.
7. Gyurko R, Wielbo D, Phillips MI. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept. 1993;49:167-174.
8. Wielbo D, Sernia C, Gyurko R, Phillips MI. Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension. 1995;25:314-319.
9. Gordon FJ, Haywood JR, Brody MJ, Johnson AK. Effect of lesions of the anteroventral third ventricle (AV3V) on the development of hypertension in spontaneously hypertensive rats. Hypertension. 1982; 4:387-393.
10. Bellin SI, Landas SK, Johnson AK. Selective catecholamine depletion of structures along the ventral lamina terminalis: effects on experimentally-induced drinking and pressor responses. Brain Res. 1988;456:9-16.
11. Bellin SI, Landas SK, Johnson AK. Localized injections of 6-hydroxydopamine into lamina terminalis-associated structures: effects of experimentally induced drinking and pressor responses. Brain Res. 1987;416:75-83.
12. Nelson DO. Altered angiotensin II sensitivity of neurons in the organum vasculosum lamina terminalis region of the spontaneously hypertensive rat. Brain Res. 1988;444:46-52.
13. Yao H, Matsumoto T, Hirano M, Kuroki T, Tsutsumi T, Uchimura H, Nakamura K, Nakahara T, Fujishima M. Involvement of brain stem noradrenergic neurons in the development of hypertension in spontaneously hypertensive rats. Neurochem Res. 1989;14:75-79.
14. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. New York, NY: Academic Press; 1986.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem. 1951;193:265-275.
16. Sumners C, Phillips MI. Central injection of angiotensin II alters catecholamine activity in rat brain. Am J Physiol. 1983;244: R257-R263.
17. Versteeg DHG, Palkovits M, Gugten JVD, Wijnen HLJM, Smeets GWM, De Jong W. Catecholamine content of individual brain regions of spontaneously hypertensive rats (SH-rats). Brain Res. 1976;112:429-434.
18. Saavedra JM, Grobecker H, Axelrod J. Changes in central catecholaminergic neurons in the spontaneously (genetic) hypertensive rat. Circ Res. 1978;42:529-534.
19. Patel KP, Kline RL, Mercer PF. Noradrenergic mechanisms in the brain and peripheral organs of normotensive and spontaneously hypertensive rats at various ages. Hypertension. 1981;3:682-690.
20. Patel KP, Ciriello J, Kline RL. Noradrenergic mechanisms in brain and peripheral organs after aortic nerve transection. Am J Physiol. 1981;240:H481-H486.
21. Patel KP, Whiteis CA, Lund DD, Schmid PG. Effects of intravenous infusions of vasopressin and angiotensin II on central and peripheral noradrenergic function in conscious rabbits. Can J Physiol Pharmacol. 1987;65:765-772.
22. Qadri F, Badoer E, Stadler T, Unger T. Angiotensin II-induced noradrenaline release from anterior hypothalamus in conscious rats: a brain microdialysis study. Brain Res. 1991;563:137-141.
23. 3H-norepinephrine release in central tissue of spontaneously hypertensive rats but not in Wistar-Kyoto rats: effect of sodium depletion. J Cardiovasc Pharmacol. 1986;8:582-587.
24. Hartle DK, Brody MJ. The angiotensin II pressor system of the rat forebrain. Circ Res. 1984;54:355-366.
25. Wyss JM, Chen YF, Jin H, Gist R, Oparil S. Spontaneously hypertensive rats exhibit reduced hypothalamic noradrenergic input after NaCl loading. Hypertension. 1987;10:313-320.
26. Chen YF, Meng Q, Wyss JM, Jin H, Oparil S. High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats. Hypertension. 1988;11:55-62.
27. Yang RH, Jin H, Wyss JM, Oparil S. Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus. Hypertension. 1992;19:475-481.
28. Johnson AK. The periventricular anteroventral third ventricle (AV3V): its relationship with the subfornical organ and neural systems involved in maintaining body fluid homeostasis. Brain Res Bull. 1985;15:595-601.